secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0001493152-24-051890
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics announces $3.5M registered direct offering of 709,220 shares and warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$3.5M from 709,220 shares at $4.935 each; warrants exercisable at $4.81 for two years.
- Additional ~$3.4M if warrants fully exercised; net proceeds for working capital and general corporate purposes.
- H.C. Wainwright receives 7% cash fee, 1% management fee, and placement agent warrants for 49,645 shares at $6.1688.
- Closing expected Dec 24, 2024; 45-day lock-up on share issuance and one-year restriction on variable rate transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224051890/0001493152-24-051890-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224051890/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-051890

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer